Sec Form 4 Filing - FRY JOHN A @ vTv Therapeutics Inc. - 2022-07-01

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person FRY JOHN A 2. Issuer Name and Ticker or Trading Symbol vTv Therapeutics Inc. [ VTVT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 310 3. Date of Earliest Transaction (MM/DD/YY) 07/01/2022 (Street) HIGH POINT, NC27265 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Director stock option (right to buy) $ 0.72 07/01/2022 A 137,077 ( 1 ) 07/01/2032 Class A Common Stock 137,077 $ 0 137,077 D Director stock option (right to buy) $ 5.35 ( 3 ) 05/12/2026 Class A Common Stock 17,500 17,500( 2 ) D Director stock option (right to buy) $ 5.31 ( 4 ) 05/01/2027 Class A Common Stock 15,000 15,000( 2 ) D Director stock option (right to buy) $ 1.79 ( 5 ) 04/30/2028 Class A Common Stock 15,000 15,000( 2 ) D Director stock option (right to buy) $ 1.45 ( 6 ) 04/29/2029 Class A Common Stock 15,000 15,000( 2 ) D Director stock option (right to buy) $ 2.65 ( 7 ) 06/11/2030 Class A Common Stock 15,000 15,000( 2 ) D Director stock option (right to buy) $ 2.54 ( 8 ) 05/03/2031 Class A Common Stock 15,000 15,000( 2 ) D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other FRY JOHN A C/O VTV THERAPEUTICS INC. 3980 PREMIER DRIVE, SUITE 310 HIGH POINT, NC27265 X Signatures /s/ Richard S. Nelson as Attorney-in-Fact 07/06/2022 Signature of Reporting Person Date

Explanation of Responses:

( 1 )An option to purchase 80,128 shares vested immediately on July 1, 2022. The remaining option to purchase 56,949 shares vests on June 1, 2023. ( 2 )On May 16, 2016, May 3, 2017, May 2, 2018, May 1, 2019, June 15, 2020 and May 5, 2021, the reporting person filed Form 4s which inadvertently aggregated options to purchase shares of Class A common stock with different exercise prices and expiration dates. These errors have been corrected in the options beneficially owned in this Form 4. ( 3 )An option to purchase 138 shares vested immediately on May 12, 2016. The remaining option to purchase 17,362 shares vests in equal monthly installments over the three-year period beginning on May 12, 2016. ( 4 )Vests in equal monthly installments over the three-year period beginning on May 1, 2017. ( 5 )Vests in equal monthly installments over the three-year period beginning on April 30, 2018. ( 6 )Vests in equal monthly installments over the three-year period beginning April 29, 2019. ( 7 )Vests in equal monthly installments over the three-year period beginning June 11, 2020. ( 8 )Vests in equal monthly installments over the three-year period beginning May 3, 2021.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.